Jonathan Lloyd Jones
Overview
Jonathan Lloyd Jones received an average of $381K in total compensation, including $275K in salary, at Neuralstem from 2015 to 2017. Jonathan Jones also received an average of $506K at Juniper Pharmaceuticals between 2013 and 2014.
Source: SEC filings on April 25, 2018, May 1, 2017, and June 4, 2015.
Related executives
We found 19 more executives who work or worked at Neuralstem and Juniper Pharmaceuticals.
Kenneth Carter
Neuralstem
Chairman
Matthew Kalnik
Neuralstem
Chief Operating Officer
Dane Saglio
Neuralstem
Chief Financial Officer
James Scully
Neuralstem
Chief Executive, President
Richard Daly
Neuralstem
Former Chief Executive, President
Alicia Secor
Juniper Pharmaceuticals
Chief Executive Officer
George Elston
Juniper Pharmaceuticals
Chief Financial Officer
Frank Condella
Juniper Pharmaceuticals